Innovative public-private partnership to target subsidised antimalarials: A study protocol for a cluster randomised controlled trial to evaluate a community intervention in Western Kenya

BMJ Open

Volumn 7, Issue 3, 2017, Pages

  Laktabai, Jeremiah ^a   Lesser, Adriane ^b   Platt, Alyssa ^b   Maffioli, Elisa ^b,c   Mohanan, Manoj ^b,c   Menya, Diana ^d   Prudhomme O'Meara, Wendy ^b,d,e   Turner, Elizabeth L ^b  

^a Moi School of Medicine   (Kenya)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

^d MOI UNIVERSITY   (Kenya)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antimalarial subsidies; community health volunteers; malaria; rapid diagnostic test

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT;

ADOLESCENT; ADULT; ANTIPROTOZOAL THERAPY; ARTICLE; CHILD; CLINICAL EVALUATION; COMBINATION DRUG THERAPY; COMMUNITY CARE; COMMUNITY TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COST; FEMALE; FEVER; HEALTH CARE DELIVERY; HEALTH IMPACT ASSESSMENT; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; INTERNAL VALIDITY; INTERVENTION STUDY; KENYA; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALARIA RAPID TEST; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VOLUNTARY WORKER; WORLD HEALTH ORGANIZATION; CLUSTER ANALYSIS; ECONOMICS; HEALTH AUXILIARY; MALE; METHODOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMMUNITY HEALTH WORKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; KENYA; MALARIA; MALE; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RESEARCH DESIGN; YOUNG ADULT;

EID: 85015922543     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-013972     Document Type: Article

References (24)

1. Abuya TO, Mutemi W, Karisa B, et al. Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J 2007;6:57.
2. Amin AA, Marsh V, Noor AM, et al. The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya. Trop Med Int Health 2003;8:1143-52.
3. Chuma J, Abuya T, Memusi D, et al. Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Malar J 2009; 8:243.
4. Malik EM, Hanafi K, Ali SH, et al Treatment-seeking behaviour for malaria in children under five years of age: implication for home management in rural areas with high seasonal transmission in Sudan. Malar J 2006;5:60.
5. Littrell M, Gatakaa H, Evance I, et al. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J 2011;10:327.
6. World Health Organization. World Malaria Report. Geneva, 2012(a).
7. World Health Organization. Q&A on the Affordable Medicines Facility malaria (AMFm) Secondary Q&A on the Affordable Medicines Facility malaria (AMFm). 2012(b). http://www.who.int/malaria/media/ affordable-medicines-facility-qa/en/
8. Tougher S, Ye Y, Amuasi JH, et al. Effect of the Affordable Medicines Facility - malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 2012;380:1916-26.
9. Mangham LJ, Cundill B, Achonduh OA, et al. Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon. Trop Med Int Health 2012;17:330-42.
10. Cohen J, Dupas P, Schaner SG. Price subsidies, diagnostic tests, and targeting of malaria treatment: evidence from a randomized controlled trial. Am Econ Rev 2015;105:609-45.
11. Briggs MA, Kalolella A, Bruxvoort K, et al. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies. PLoS One 2014;9:e94074.
12. ACTwatch PSIa. Kenya Outlet Survey Findings 2010-2014. ACTwatch Research Brief. Washington DC, USA: ACTwatch Research Brief, 2015.
13. Kioko U, Riley C, Dellicour S, et al. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013. Malar J 2016;15:359.
14. Hamer DH, Brooks ET, Semrau K, et al. Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers. Pathog Glob Health 2012;106:32-9.
15. Chanda P, Hamainza B, Moonga HB, et al. Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers. Malar J 2011;10:158.
16. Republic of Kenya Ministry of Health. Community Strategy Implementation Guidelines for Managers of the Kenya Essential Package for Health at the Community Level. 2007. https://www.slideshare.net/chskenya/community-healthstrategyimplementationguide2007
17. Murray DM. Design and analysis of group-randomized trials. Oxford, UK: Oxford University Press, 1998.
18. Prudhomme O'Meara W, Mohanan M, Laktabai J, et al. Assessing the independent and combined effects of subsidies for antimalarials and rapid diagnostic testing on fever management decisions in the retail sector: results from a factorial randomised trial in western Kenya. BMJ Global Health 2016;1:e000101.
19. Abba K, Deeks JJ, Olliaro P, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev 2011;(7):Cd008122.
20. World Health Organization. Training module on malaria control: case management. Malta: World Health Organization, 2012(c).
21. Republic of Kenya Ministry of Health. National guidelines for the diagnosis, treatment and prevention of malaria in Kenya. 4th edn, 2014.
22. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 1996;86:726-8.
23. Hayes RJ, Moulton LH. Cluster randomised trials. Boca Raton, FL: CRC Press, 2009.
24. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. The Ann Stat 2001;29:1165-88.